Federated Hermes’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$941K Buy
190,010
+2,333
+1% +$11.3K ﹤0.01% 1132
2025
Q4
$876K Sell
187,677
-22,323
-11% -$101K ﹤0.01% 1159
2025
Q3
$1,000K Sell
210,000
-10,000
-5% -$34.4K ﹤0.01% 1148
2025
Q2
$682K Buy
220,000
+31,000
+16% +$92.4K ﹤0.01% 1248
2025
Q1
$627K Buy
189,000
+89,000
+89% +$313K ﹤0.01% 1242
2024
Q4
$312K Buy
100,000
+28,819
+40% +$98.1K ﹤0.01% 1418
2024
Q3
$259K Buy
71,181
+8,181
+13% +$33.2K ﹤0.01% 1444
2024
Q2
$289K Buy
63,000
+23,000
+58% +$112K ﹤0.01% 1419
2024
Q1
$197K Sell
40,000
-80,000
-67% -$386K ﹤0.01% 1494
2023
Q4
$565K Sell
120,000
-40,000
-25% -$150K ﹤0.01% 1312
2023
Q3
$408K Buy
160,000
+80,000
+100% +$254K ﹤0.01% 1398
2023
Q2
$358K Buy
80,000
+15,487
+24% +$70K ﹤0.01% 1463
2023
Q1
$321K Sell
64,513
-35,487
-35% -$115K ﹤0.01% 1511
2022
Q4
$206K Buy
+100,000
New +$225K ﹤0.01% 1552

Other funds holding SOPH

Federated Hermes's SOPH Position: Q1 2026 in Review

Federated Hermes increased its SOPHiA GENETICS (SOPH) stake by 1.2% in Q1 2026, buying an estimated $11.3K and bringing the position to 190,010 shares worth $941K. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Federated Hermes first reported a position in SOPH in Q4 2022 and has held it in 14 quarters since. The position peaked at $1,000K in Q3 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Federated Hermes held 190,010 shares of SOPHiA GENETICS worth $941K as of Q1 2026.
  • Federated Hermes bought 2,333 SOPHiA GENETICS shares in Q1 2026, an estimated $11.3K.
  • SOPHiA GENETICS made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1132 holding.
  • Federated Hermes first reported a position in SOPHiA GENETICS in Q4 2022 and has held it in 14 quarters since.
  • Federated Hermes's SOPHiA GENETICS position peaked at $1,000K in Q3 2025.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.